Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sleep Number Corporation SEC filings document its personalized sleep-products business, capital structure and public-company governance. Form 8-K disclosures cover operating results, Regulation FD investor presentations, amendments to its credit agreement, covenant and liquidity terms, financing arrangements, officer appointments, board changes and compensatory arrangements.
The company’s proxy materials describe director matters, executive compensation, equity awards and shareholder voting items. Together, the filings provide formal records for Sleep Number’s direct-to-consumer retail model, product and marketing strategy, debt obligations, internal reporting roles and governance practices.
BlackRock, Inc. filed an Amendment No. 9 to Schedule 13G/A concerning Common Stock of Sleep Number Corporation. The filing reports 0 shares beneficially owned, representing 0.0% of the class as of the cover date 06/30/2026. The submission states the ownership figures reflect certain Reporting Business Units of BlackRock, Inc., and lists standard disclosures about ownership on behalf of others. The form is signed by Spencer Fleming on 07/08/2026.
Sleep Number Corp — Amendment No. 2 to a Schedule 13G/A was filed by Pacific Ridge Capital Partners, LLC reporting 0 shares beneficially owned of Sleep Number common stock, representing 0.0% of the class. The filing is signed by Peter Trumbo, C.C.O., dated 06/24/2026.
Sleep Number Corp: Schedule 13G reports a passive institutional holding. Jane Street Group, LLC and its affiliates report beneficial ownership of 1,401,197 shares of Sleep Number common stock, representing 6.1% of the class. Related subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC hold 577,929 and 823,268 shares respectively, with shared voting and dispositive power reported.
The filing is signed by an authorized signatory on 06/23/2026 and lists the issuer's principal executive offices in Minneapolis.
Sleep Number Corp director Julie Howard reported an open-market sale of company stock. She sold 10,585 shares of Sleep Number common stock in a single transaction on 2026-06-22 at a price of $0.1346 per share. After this sale, she directly holds 37,580 shares of Sleep Number common stock, indicating she retains a meaningful ongoing ownership stake in the company.
Sleep Number Corp ownership disclosure: AQR Capital Management entities report 1,755,148 shares of Common Stock, representing 7.61% of the class as of 06/15/2026. The filing attributes the holding to related AQR entities with shared voting and dispositive power across the group.
The schedule notes that AQR Capital Management II, LLC manages investment funds that hold portions of these shares and that AQR Capital Management Holdings, LLC is the parent of the reporting subsidiaries.
Sleep Number Corp director Angel L. Mendez sold 3,020 shares of Common Stock in an open-market transaction on June 18, 2026 at a price of $0.2205 per share. After this sale, Mendez directly holds 34,495 shares of Sleep Number common stock.
Sleep Number Corp EVP Chief Legal & Risk Officer Samuel R. Hellfeld reported an open-market sale of 7,964 common shares held indirectly through a 401k plan at an average price of $0.31 per share on June 18, 2026. Following these transactions, he continues to hold 75,772 Sleep Number shares directly, indicating that only his indirect 401k position was fully sold while a larger direct stake remains.
Sleep Number Corporation reported that Nasdaq has decided to delist its common stock following the company’s recent Chapter 11 bankruptcy filings. Nasdaq cited the Chapter 11 Cases, public interest concerns, questions about any residual equity value for common shareholders, and doubts about ongoing listing compliance.
Trading in Sleep Number’s common stock on the Nasdaq Global Select Market will be suspended at the start of business on June 23, 2026, after which Nasdaq plans to file Form 25-NSE to remove the listing. The company will not appeal this determination and does not expect the delisting to affect its business operations or the Chapter 11 proceedings. The stock may trade on over-the-counter markets, but the company gives no assurance that such trading or an efficient market will develop.